Rohit Aggarwal is an Associate Professor of medicine at the University of Pittsburgh and medical director of the Arthritis and Autoimmunity Center at the University of Pittsburgh Medical Center (UPMC), USA. He is the co-director of UPMC Myositis Center. His areas of interest are clinical and translational research in inflammatory muscle diseases, specifically myositis and associated interstitial lung disease.
Dr Aggarwal is an established independent clinical investigator with significant funding from NIH, foundations, and industry, and currently leads several international collaborations. He has maintained an extremely high publication record and has demonstrated national and international recognition of his work. He continues to be a leader in disease criteria and outcomes measures in myositis, as well as in clinical trials of novel therapeutic agents for myositis. Dr Aggarwal is also involved in mentoring future generations of rheumatologists with great success, and attracting younger rheumatologists towards myositis research for the advancement of the field.
Dr Aggarwal has also published several key articles on anti-synthetase syndrome and has recently received a prestigious ACR/EULAR grant for development and validation of classification criteria for anti-synthetase syndrome.